Home / Fesoterodine / Belgium
BE ATC G04BD11 · updated 2 Nov 2026
Fesoterodine shortage in Belgium
Is there a Fesoterodine shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Fesoterodine product is reported short in Belgium, the first since 14 Nov 2023. The company estimate for the return is 24 Jun 2027. Main reason: other.
Also short in Ireland. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Toviaz 4 mg (Abacus Medicine) tabl. prol.-rel. 84 | Pfizer Europe MA | 14 Nov 2023 | 24 Jun 2027 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.